GlaxoSmithKline | مبيعات



Sales تغيير تاريخ
AbbVie USD 13.34B 1.76B 2025-03
Alcon AG USD 2.48B 26M 2024-12
Almirall EUR 248.42M 382K 2024-06
Amgen USD 8.15B 936M 2025-03
argenx SE USD 671.52M 129.45M 2024-12
AstraZeneca USD 13.59B 1.3B 2025-03
Bayer EUR 11.73B 1.76B 2024-12
Biogen USD 2.43B 24.7M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Eli Lilly USD 12.73B 802.8M 2025-03
Fresenius EUR 5.5B 130M 2024-12
Fresenius Medical Care EUR 5.07B 250M 2024-12
Galapagos EUR 74.98M 870K 2025-03
Genmab DKK 64.41B 58.87B 2024-12
Gilead Sciences USD 6.67B 899M 2025-03
GlaxoSmithKline GBP 7.52B 600M 2025-03
Glaxosmithkline GBP 8.12B 105M 2024-12
GRIFOLS EUR 1.94B 150M 2024-12
Hikma Pharmaceutical USD 1.57B 121M 2024-06
Lonza CHF 3.06B 580M 2024-06
Merck EUR 5.42B 152M 2024-12
Merck USD 15.53B 94M 2025-03
Novartis USD 13.15B 330M 2024-12
Novo Nordisk 85.68B 14.37B 2024-12
Orion EUR 354.6M 79.8M 2025-03
Pfizer USD 13.72B 4.04B 2025-03
Philips EUR 5.04B 644M 2024-12
Recordati EUR 583.6M 26.19M 2024-12
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 9.9B 660M 2025-03
Smith & Nephew USD 1.41B 1.42B 2024-12
UCB EUR 2.79B 127M 2024-06



GlaxoSmithKline مبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.